Active Funding

PHF8 Promotes Prostate Cancer Metastasis by Epigenetically Upregulating RIPK2
SBU OVPR (PI: Yang)
08/01/2024 – 02/01/2026

RIPK2/MKK7/c-Myc Signaling as a Therapeutic Target in Prostate Cancer Metastasis
NIH/NCI 7R01CA266694-03 (PI: Yang)
06/01/2024 – 05/31/2028

RIPK2 as a Therapeutic Target in Advanced Prostate Cancers
DoD PCRP Translational Science Award W81XWH2210131 (PI: Yang)
06/01/2022 – 05/31/2025

The Palmitoylating Enzyme DHHC11 Promotes Prostate Cancer Progression and Metastasis
DoD PCPR Exploration – Hypothesis Development Award HT94252310028 (PI: Yang)
01/01/2023-12/31/2024